← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2023-06-30 · Filed 2023-08-14 · Accession 0001420506-23-001695
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | ACELYRIN INC | COM · 00445A100 | LONG | 500,000 | $10.4 million |
| 2 | ACLARIS THERAPEUTICS INC | COM · 00461U105 | LONG | 2,901,194 | $30.1 million |
| 3 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 648,451 | $4.4 million |
| 4 | AGENUS INC | COM NEW · 00847G705 | LONG | 4,697,930 | $7.5 million |
| 5 | ALECTOR INC | COM · 014442107 | LONG | 4,131,315 | $24.8 million |
| 6 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 224,030 | $79.2 million |
| 7 | ALPHATEC HLDGS INC | COM NEW · 02081G201 | LONG | 25,431 | $457,249 |
| 8 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 70,750,000 | $82.4 million |
| 9 | ALX ONCOLOGY HLDGS INC | COM · 00166B105 | LONG | 1,249,900 | $9.4 million |
| 10 | AMYRIS INC | NOTE 1.500%11/1 · 03236MAJ0 | LONG | 137,850,000 | $26.2 million |
| 11 | ANAPTYSBIO INC | COM · 032724106 | LONG | 1,154,423 | $23.5 million |
| 12 | ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 · 04351PAD3 | LONG | 124,000,000 | $113.2 million |
| 13 | AXONICS INC | COM · 05465P101 | LONG | 573,791 | $29.0 million |
| 14 | BIOCRYST PHARMACEUTICALS INC | COM · 09058V103 | LONG | 2,791,880 | $19.7 million |
| 15 | BIOGEN INC | COM · 09062X103 | LONG | 121,942 | $34.7 million |
| 16 | BOSTON SCIENTIFIC CORP | COM · 101137107 | LONG | 717,050 | $38.8 million |
| 17 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 62,294,000 | $38.6 million |
| 18 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 128,338,000 | $101.1 million |
| 19 | COMPASS THERAPEUTICS INC | COM · 20454B104 | LONG | 5,954,273 | $18.9 million |
| 20 | CRINETICS PHARMACEUTICALS IN | COM · 22663K107 | LONG | 650,312 | $11.7 million |
| 21 | CULLINAN THERAPEUTICS INC | COM · 230031106 | LONG | 1,908,865 | $20.5 million |
| 22 | CUTERA INC | NOTE 2.250% 6/0 · 232109AD0 | LONG | 11,500,000 | $7.2 million |
| 23 | DANAHER CORP DEL | COM · 235851102 | LONG | 55,400 | $13.3 million |
| 24 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 3,361,813 | $40.1 million |
| 25 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 12,107,785 | $23.0 million |
| 26 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 3,646,419 | $51.3 million |
| 27 | DICE THERAPEUTICS INC | COM · 23345J104 | LONG | 1,029,901 | $47.8 million |
| 28 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 1,377,872 | $15.5 million |
| 29 | ENANTA PHARMACEUTICALS INC | COM · 29251M106 | LONG | 1,038,310 | $22.2 million |
| 30 | ESPERION THERAPEUTICS INC NE | COM · 29664W105 | LONG | 895,949 | $1.2 million |
| 31 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 131,000,000 | $134.7 million |
| 32 | GLAUKOS CORP | COM · 377322102 | LONG | 1,044,392 | $74.4 million |
| 33 | GUARDANT HEALTH INC | NOTE 11/1 · 40131MAB5 | LONG | 268,252,000 | $193.1 million |
| 34 | GUARDANT HEALTH INC | COM · 40131M109 | LONG | 270,000 | $9.7 million |
| 35 | HARROW INC | COM · 415858109 | LONG | 1,452,538 | $27.7 million |
| 36 | HILLEVAX INC | COM · 43157M102 | LONG | 1,249,246 | $21.5 million |
| 37 | ILLUMINA INC | NOTE 8/1 · 452327AK5 | LONG | 22,645,000 | $22.6 million |
| 38 | IMMUNOCORE HLDGS PLC | ADS · 45258D105 | LONG | 468,027 | $28.1 million |
| 39 | INSMED INC | NOTE 0.750% 6/0 · 457669AB5 | LONG | 3,500,000 | $3.0 million |
| 40 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 39,963,000 | $38.0 million |
| 41 | INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 · 457985AM1 | LONG | 14,500,000 | $13.3 million |
| 42 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 123,820 | $42.3 million |
| 43 | INVITAE CORP | NOTE 2.000% 9/0 · 46185LAB9 | LONG | 16,781,000 | $15.0 million |
| 44 | IONIS PHARMACEUTICALS INC | NOTE 4/0 · 462222AD2 | LONG | 52,740,000 | $50.0 million |
| 45 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 478,557 | $49.9 million |
| 46 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $43.0 million |
| 47 | KEROS THERAPEUTICS INC | COM · 492327101 | LONG | 1,143,865 | $46.0 million |
| 48 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 108,108 | $12.7 million |
| 49 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 133,291 | $15.6 million |
| 50 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 556,301 | $38.4 million |
| 51 | MARAVAI LIFESCIENCES HLDGS I | COM CL A · 56600D107 | LONG | 1,804,700 | $22.4 million |
| 52 | MERUS N V | COM · N5749R100 | LONG | 1,543,162 | $40.6 million |
| 53 | MINERALYS THERAPEUTICS INC | COM · 603170101 | LONG | 550,300 | $9.4 million |
| 54 | MIRATI THERAPEUTICS INC | COM · 60468T105 | LONG | 240,625 | $8.7 million |
| 55 | NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 · 63009RAD1 | LONG | 145,520,000 | $115.4 million |
| 56 | NATERA INC | COM · 632307104 | LONG | 1,152,851 | $56.1 million |
| 57 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 28,000,000 | $26.3 million |
| 58 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 48,678,000 | $36.1 million |
| 59 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 933,362 | $88.0 million |
| 60 | NEVRO CORP | NOTE 2.750% 4/0 · 64157FAC7 | LONG | 109,251,000 | $100.9 million |
| 61 | NEVRO CORP | COM · 64157F103 | LONG | 1,776,368 | $45.2 million |
| 62 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 135,834,000 | $118.2 million |
| 63 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 55,323,000 | $50.1 million |
| 64 | NUVATION BIO INC | COM CL A · 67080N101 | LONG | 4,122,900 | $7.4 million |
| 65 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 761,208 | $33.4 million |
| 66 | OUTSET MED INC | COM · 690145107 | LONG | 1,460,368 | $31.9 million |
| 67 | PARAGON 28 INC | COM · 69913P105 | LONG | 2,136,122 | $37.9 million |
| 68 | PENUMBRA INC | COM · 70975L107 | LONG | 65,844 | $22.7 million |
| 69 | PULMONX CORP | COM · 745848101 | LONG | 999,362 | $13.1 million |
| 70 | RAPT THERAPEUTICS INC | COM · 75382E109 | LONG | 984,400 | $18.4 million |
| 71 | REPLIGEN CORP | COM · 759916109 | LONG | 92,000 | $13.0 million |
| 72 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 487,520 | $11.3 million |
| 73 | RHYTHM PHARMACEUTICALS INC | COM · 76243J105 | LONG | 843,087 | $13.9 million |
| 74 | SEAGEN INC | COM · 81181C104 | LONG | 42,497 | $8.2 million |
| 75 | TERNS PHARMACEUTICALS INC | COM · 880881107 | LONG | 1,842,352 | $16.1 million |
| 76 | THERMO FISHER SCIENTIFIC INC | COM · 883556102 | LONG | 27,300 | $14.2 million |
| 77 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 28,350,000 | $22.8 million |
| 78 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $50.5 million |
| 79 | VAXCYTE INC | COM · 92243G108 | LONG | 1,722,353 | $86.0 million |
| 80 | VIR BIOTECHNOLOGY INC | COM · 92764N102 | LONG | 728,549 | $17.9 million |
| 81 | VIRIDIAN THERAPEUTICS INC | COM · 92790C104 | LONG | 1,206,300 | $28.7 million |
| 82 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 1,828,353 | $70.4 million |